Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Rheumatoid Arthritis

  Free Subscription


15.04.2019

1 Ann Rheum Dis
7 Arthritis Res Ther
2 Clin Exp Rheumatol
2 Clin Rheumatol
1 Intern Med
1 J Immunol
2 PLoS One
2 Rheumatol Int
3 Scand J Rheumatol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Rheum Dis

  1. VAN MULLIGEN E, de Jong PHP, Kuijper TM, van der Ven M, et al
    Gradual tapering TNF inhibitors versus conventional synthetic DMARDs after achieving controlled disease in patients with rheumatoid arthritis: first-year results of the randomised controlled TARA study.
    Ann Rheum Dis. 2019 Apr 6. pii: annrheumdis-2018-214970.
    PubMed     Text format     Abstract available


    Arthritis Res Ther

  2. WOLLENHAUPT J, Lee EB, Curtis JR, Silverfield J, et al
    Safety and efficacy of tofacitinib for up to 9.5 years in the treatment of rheumatoid arthritis: final results of a global, open-label, long-term extension study.
    Arthritis Res Ther. 2019;21:89.
    PubMed     Text format     Abstract available

  3. EBINA K, Hashimoto M, Yamamoto W, Hirano T, et al
    Drug tolerability and reasons for discontinuation of seven biologics in 4466 treatment courses of rheumatoid arthritis-the ANSWER cohort study.
    Arthritis Res Ther. 2019;21:91.
    PubMed     Text format     Abstract available

  4. TEN BRINCK RM, Toes REM, van der Helm-van Mil AHM
    Inflammation functions as a key mediator in the link between ACPA and erosion development: an association study in Clinically Suspect Arthralgia.
    Arthritis Res Ther. 2018;20:89.
    PubMed     Text format     Abstract available

  5. TEN CATE DF, Jacobs JWG, Swen WAA, Hazes JMW, et al
    Can baseline ultrasound results help to predict failure to achieve DAS28 remission after 1 year of tight control treatment in early RA patients?
    Arthritis Res Ther. 2018;20:15.
    PubMed     Text format     Abstract available

  6. CHENG TT, Yu SF, Su FM, Chen YC, et al
    Anti-CCP-positive patients with RA have a higher 10-year probability of fracture evaluated by FRAX(R): a registry study of RA with osteoporosis/fracture.
    Arthritis Res Ther. 2018;20:16.
    PubMed     Text format     Abstract available

  7. ALTEN R, Burkhardt H, Feist E, Kruger K, et al
    Abatacept used in combination with non-methotrexate disease-modifying antirheumatic drugs: a descriptive analysis of data from interventional trials and the real-world setting.
    Arthritis Res Ther. 2018;20:1.
    PubMed     Text format     Abstract available

  8. BOER AC, Ten Brinck RM, Evers AWM, van der Helm-van Mil AHM, et al
    Does psychological stress in patients with clinically suspect arthralgia associate with subclinical inflammation and progression to inflammatory arthritis?
    Arthritis Res Ther. 2018;20:93.
    PubMed     Text format     Abstract available


    Clin Exp Rheumatol

  9. SZEKANECZ Z, Koncz A, Dunkel J, Vencovsky J, et al
    Cigarette smoking and clinical response to certolizumab pegol treatment in Hungarian, Czech, and Slovak patients with rheumatoid arthritis: 104-week data from the CIMDORA prospective, non-interventional study.
    Clin Exp Rheumatol. 2019 Apr 9. pii: 13453.
    PubMed     Text format     Abstract available

  10. SKAPENKO A, Smolen JS, Kavanaugh A, Arora V, et al
    Genetic markers associated with clinical and radiographic response in adalimumab plus methotrexate-treated rheumatoid arthritis patients in OPTIMA.
    Clin Exp Rheumatol. 2019 Apr 9. pii: 13260.
    PubMed     Text format     Abstract available


    Clin Rheumatol

  11. ZHAO WH, Zhang LX, Liu CX, Niedermann K, et al
    Validation of the Chinese version of joint protection self-efficacy scale in patients with rheumatoid arthritis.
    Clin Rheumatol. 2019 Apr 10. pii: 10.1007/s10067-019-04510.
    PubMed     Text format     Abstract available

  12. ALTEN R, Mariette X, Lorenz HM, Nusslein H, et al
    Correction to: Predictors of abatacept retention over 2 years in patients with rheumatoid arthritis: results from the real-world ACTION study.
    Clin Rheumatol. 2019 Apr 11. pii: 10.1007/s10067-019-04545.
    PubMed     Text format     Abstract available


    Intern Med

  13. YAMASAKI G, Okano M, Nakayama K, Jimbo N, et al
    Acute Pulmonary Hypertension Crisis after Adalimumab Reduction in Rheumatoid Vasculitis.
    Intern Med. 2019;58:593-601.
    PubMed     Text format     Abstract available


    J Immunol

  14. PANNETON V, Bagherzadeh Yazdchi S, Witalis M, Chang J, et al
    ICOS Signaling Controls Induction and Maintenance of Collagen-Induced Arthritis.
    J Immunol. 2018;200:3067-3076.
    PubMed     Text format     Abstract available


    PLoS One

  15. MAKIN K, Easter T, Kemp M, Kendall P, et al
    Undetectable mannose binding lectin is associated with HRCT proven bronchiectasis in rheumatoid arthritis (RA).
    PLoS One. 2019;14:e0215051.
    PubMed     Text format     Abstract available

  16. GONZALEZ-ALVARO I, Castrejon I, Carmona L
    The comparative responsiveness of Hospital Universitario Princesa Index and other composite indices for assessing rheumatoid arthritis activity.
    PLoS One. 2019;14:e0214717.
    PubMed     Text format     Abstract available


    Rheumatol Int

  17. WU GC, Tao SS, Zhao CN, Mao YM, et al
    Leveraging Google Trends to investigate the global public interest in rheumatoid arthritis.
    Rheumatol Int. 2019 Apr 6. pii: 10.1007/s00296-019-04297.
    PubMed     Text format     Abstract available

  18. YANG JH, Kwon HH, Lee JK, Bang SY, et al
    Successful arthroscopic treatment of refractory and complicated popliteal cyst associated with rheumatoid arthritis in combination with osteoarthritis: case series and literature review.
    Rheumatol Int. 2019 Apr 11. pii: 10.1007/s00296-019-04278.
    PubMed     Text format     Abstract available


    Scand J Rheumatol

  19. MOLANO-GONZALEZ N, Olivares-Martinez E, Anaya JM, Hernandez-Molina G, et al
    Anti-citrullinated protein antibodies and arthritis in Sjogren's syndrome: a systematic review and meta-analysis.
    Scand J Rheumatol. 2019;48:157-163.
    PubMed     Text format     Abstract available

  20. WATANABE T, Takahashi Y, Hirabayashi K, Tomaru U, et al
    Acute fulminant myocarditis in a patient with primary Sjogren's syndrome.
    Scand J Rheumatol. 2019;48:164-165.
    PubMed     Text format    

  21. NILSSON AM, Tufvesson E, Hesselstrand R, Olsson P, et al
    Increased B-cell activating factor, interleukin-6, and interleukin-8 in induced sputum from primary Sjogren's syndrome patients.
    Scand J Rheumatol. 2019;48:149-156.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Rheumatoid Arthritis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: